A smart hospital-driven approach to precision pharmacovigilance
페이지 정보
본문
Researchers, regulatory authorities, and the pharmaceutical industry are moving toward precision pharmacovigilance as a comprehensive framework for drug safety assessment tailored to individual patient services by clustering specific risk groups across different databases.
Precision pharmacovigilance implementation includes:
(i) Designing new data collection infrastructure
(ii) Exploring new computational methods suitable for drug safety data
(iii) Providing computer-assisted frameworks for distributed clinical decision-making with the aim of developing personalized information leaflets containing specific references to drug risks and adverse effects
These goals can be achieved by using “smart hospitals” as key data sources and complementing current public health decision-making with precision medicine and healthcare statistical methodologies.
